FDCTech Inc (PK) (FDCT) Share Price

Stellar technicals. I look at the 5 year monthly analysis for the bigger picture. Unable to post the monthly but here's a 3 month daily.
https://stockcharts.com/sc3/ui/?s=FDCT

ready to turn around this week, correction overdone imo.

Shares updated. No Change.
https://www.otcmarkets.com/stock/FDCT/security

Shares updated. No changes.
https://www.otcmarkets.com/stock/FDCT/security

MMS will have a massive cover before that scenario plays out. The 8k serves a multi-purpose here.
The next cover run should take this into the 20s or higher.
Just my take.

When an OTC (Over-The-Counter) company voluntarily delists from the OTC market and proceeds with an Initial Public Offering (IPO) on the NYSE (New York Stock Exchange), here's what typically happens to your shares:

1. **Suspension of Trading on OTC:**
- Once the company decides to delist, trading of the shares on the OTC market will be suspended. This usually happens after the company has made public its intention to do an IPO on the NYSE.

2. **IPO Process:**
- **Lock-Up Period:** Existing shareholders might be subject to a lock-up period where they cannot sell their shares for a certain time after the IPO. This is to prevent a flood of shares hitting the market post-IPO, which could depress the share price. The duration of this lock-up varies but is commonly around 180 days.

- **Share Exchange or Conversion:** If the company decides to continue with the same share structure, your existing shares might simply be converted or exchanged for shares on the NYSE. The number of shares you hold would remain the same, but they would now be listed on the NYSE.

- **Pricing and Allocation:** During the IPO, new shares are issued at the IPO price. Existing shareholders' shares are typically not part of this new issuance unless they choose to buy more shares in the IPO. However, the market price of the shares might adjust based on the IPO pricing and market reception.

3. **Post-IPO Trading:**
- Once the IPO is completed and the lock-up period (if any) ends, your shares will be freely tradable on the NYSE. The liquidity should be much better than on the OTC market, potentially leading to more stable pricing and easier transactions.

4. **Value Impact:**
- **Potential Value Increase:** Moving to a major exchange like NYSE often enhances the perceived value of the company, which could lead to an increase in share price due to increased visibility, credibility, and investor interest.

- **Dilution:** If the company issues a significant number of new shares during the IPO, existing shares might experience dilution, potentially impacting the value of your holdings unless the market cap grows sufficiently to offset this.

5. **Shareholder Actions:**
- **Hold:** If you believe in the company's growth prospects, you might choose to hold onto your shares, especially if you expect the stock price to rise post-IPO.
- **Sell:** After any lock-up period, you could decide to sell your shares if you think the price has peaked or if you want to cash out.

6. **Communication:**
- The company will communicate these changes to shareholders via official channels, providing instructions or updates on how the shares will transition or what actions shareholders need to take.

Remember, the specifics can vary based on the company's decisions, the terms of the IPO, and the regulatory environment. Always review any documents provided by the company or consult with a financial advisor to understand your specific situation.

Uplisting from OTC to NYSE and doing an IPO directly on NYSE after voluntary delisting from OTC both have their advantages and considerations:

**Uplisting from OTC to NYSE:**
- **Advantages:**
- **Increased Credibility:** Being listed on the NYSE can enhance a company's prestige and perceived stability, potentially attracting more investors.
- **Liquidity:** NYSE generally offers higher liquidity, which can lead to better price discovery and easier buying/selling of shares.
- **Visibility:** Greater exposure to institutional investors and analysts.
- **Regulatory Compliance:** Already public, so less paperwork and regulatory scrutiny compared to an IPO.

- **Considerations:**
- **Cost:** Meeting NYSE listing requirements can be costly in terms of compliance, legal, and accounting fees.
- **Time:** The process can be time-consuming, with requirements like minimum share price, number of shareholders, etc.

**Voluntary Delisting from OTC and Doing an IPO on NYSE:**
- **Advantages:**
- **Fresh Start:** An IPO can be marketed as a new beginning, possibly at a higher valuation if timing and market conditions are right.
- **Clean Slate:** Opportunity to restructure shareholder base or address any OTC market-related issues.

- **Considerations:**
- **Complexity and Cost:** An IPO involves significant legal, auditing, and underwriting expenses. It also requires roadshows, which can be resource-intensive.
- **Regulatory Scrutiny:** More rigorous due diligence by the SEC and potentially more disclosure requirements.
- **Market Risk:** There's a risk of timing the market wrong, leading to suboptimal pricing of shares.

**Which is Better?**
- **Contextual Decision:** It largely depends on the company's current financial health, strategic goals, investor relations, and market conditions:
- **Uplisting** might be better if the company already has a solid base of shareholders, good financials, and wants to leverage its current market position for a quicker transition with potentially less disruption.
- **IPO** could be preferable if the company aims for a significant rebranding, needs capital infusion, or if there's an opportunity to fetch a higher valuation through a fresh market entry.

- **Long-term Strategy:** Consider the long-term business strategy. If the goal is rapid growth or if there's a need for substantial capital, an IPO might offer more direct benefits. If it's about enhancing credibility and market presence with less immediate capital need, uplisting could be more fitting.

In summary, there's no one-size-fits-all answer. It's critical to weigh the immediate costs against potential benefits, consider the company's readiness for the NYSE's higher standards, and align with strategic business objectives. Consulting with financial advisors, investment bankers, or legal experts would be advisable to make the most informed decision.

I didn’t mention it. Other people keep mentioning it. I’ve said over and over again that people need to stop posting about it

Not too many people dumb enough to sell down here lol.

Looking thin af

couple of buys at ask and probably at .06!!
imo

Next run buys my granddaughter a 3wheeler.

Any update on that R/S you mentioned? TIA

#2 on the breakout board.
https://investorshub.advfn.com/boards/breakoutboards.aspx

Shares updated. No change.
https://www.otcmarkets.com/stock/FDCT/security

Market cap is what matters. I’ll take the RS any day when the prize is the NYSE or Nasdaq. They’re only detrimental when it’s used as a tool to continue to dilute the stock. You want to start getting multiples gotta go to the big boards.

The week of march 10th should end the 45 day review. Probably have a definitive announcement therein as well.

Who in their right mind would welcome a reverse split? Obviously you have no clue how detrimental they are to a stock. I’m beginning to think you have an agenda. You seem to purposely want to spook people into selling. Whatever. I’m done with this

I am guess they will move to the QB once the Float issue is resolved... then the clock will start for the movement to the higher exchange... and my thinking is NYSE/American. The requirements there are a bit lower then the NYSE and with the completion of this up coming Acquisition and possibly one or two more they should be close to the minimum bid price of one dollar...They get to the one dollar and they will also have the required shareholder equity number as well. And I think the time frame is going to be closer to 9 months then 6 but the PPS will have had a significant enough jump from this level that there will never be an need for a RS in order to get there. They already have significant revenue and a nice amount of cash... this will be in good shape when the time comes. Only thing holding them back is the current Float issue and the completion of the upcoming acquisition... but they have an ace in the hole too... the Annual Report will be out in late March and if the numbers are as good as they appear to be then that will also cause a significant boost in the PPS

That would be the easiest way to regain compliance on QB, and what a statement that would make too!!

that's a good point... thanks!

Unless they reduce restricted. One of possible scenarios.

so.... OTCQB requires 10% public float. once unrestricted, won't these shares need to be sold into the float?

If they continue to show growth then ya anything’s possible.

Well it’ll come. You just let me know when you’re gonna dump lol.

Yes $1 minimum. Given the acquisition and accretive revenues, they should be good to go.

The first step is QB. Reverse split talk will scare people off if they log in here and see it. I sure as hell won’t hold if I think they are going to r/s it. I’ll dump every bit on the bid and so will many others….and It won’t recover. Put an end to the r/s talk

I believe the lowest tier in NYSE still requires minimum 1$.

The reverse split won’t be needed for the QB but the ambitions are much higher than that.

They only need to stay above a penny for 30 days to qualify for otcqb

I agree and people need to stop bringing that up. It will spook any new potential buyers

I doubt they'll need to rs going into the NYSE. I've posted that before.

You can’t Uplist without one with the current share price.

Why do people keep bringing up reverse split? This topic spooks people. The share structure here is too small for that. It needs to stop being brought up

Why do people keep bringing up reverse split? This topic spooks people. The share structure here is too small for that. It needs to stop being brought up

Good post. Right on.

Haha ya if someone was holding short positions they’d get it with no lube lol. Uplisting would be the simplest and least disruptive at least short term. If the route was Uplist they definitely would wanna regain QB status and try get share price up as high as they can to minimize the reverse split that will be needed. Either way my money is locked here for now. I trust these guys to do what’s best long term for shareholders so I’ll just go with the flow.

I don't think they would have to regain QB status as well before uplisting?? Shorts would be locked and covering at huge costs. I like it.

So that’s how that could be done. Would have to voluntarily delist from OTC first. If that’s the route they take there would be a fairly long pause to trading. But in saying that the end result would probably be better. We would get valued right from the get go with IPO. Would end up having un tradable shares again but I could live with that.

Yes, a company can voluntarily delist from the OTC Markets and later conduct an Initial Public Offering (IPO) to list on the NYSE. Here's a brief outline of the process:

1. **Voluntary Delisting from OTC**: The company would need to file with the OTC Markets to voluntarily delist its securities. This process involves notifying shareholders and complying with any regulatory requirements.

2. **Preparation for IPO**: After delisting, if the company isn't already publicly reporting, it would need to prepare for SEC registration. This includes financial audits, preparing a prospectus, and ensuring compliance with SEC regulations.

3. **Filing for IPO**: The company would file an S-1 registration statement with the SEC, detailing its business, financials, and the terms of the IPO.

4. **NYSE Listing Requirements**: To list on the NYSE, the company must meet certain criteria including minimum share price, number of shareholders, market capitalization, and corporate governance standards.

5. **IPO Execution**: Once approved by the SEC and NYSE, the company would set a date for the IPO, where shares are sold to the public, often through underwriters.

6. **Post-IPO**: After the IPO, the company's shares would begin trading on the NYSE, assuming all listing standards are met and maintained.

This process can be complex and time-consuming, involving legal, financial, and regulatory considerations. Companies typically engage with investment banks, legal advisors, and auditors to navigate this transition. Remember, the specific steps can vary based on the company's situation and current market conditions.

_Disclaimer: Grok is not a lawyer; please consult one. Don't share information that can identify you._

I had basically the same response back then. I don’t know where he’s getting it from that could do IPO. No where in my understanding is that possible. Uplist absolutely but can’t do an IPO when you’re already public to the best of my knowledge.

"The entire process from filing Form S-1 to completing an IPO on the NYSE generally takes between 3 to 6 months, though it can vary depending on specific circumstances."


On Mon, Dec 16, 2024 at 6:56?PM

Looks like the MMS don't want to paint the tape today? Gap spread containing the energy.
Typical..

I pushed back on Mitch in early December regarding the typical time frame to uplist. Since the process in underway, he was estimating 3-6 months baring any unrealistic circumstances.

should be an interesting day, to say the least...

FDCT ok lets start our journey back up today

Yep best case scenario for them and us. Not so much for... oh well, they've had plenty of notice and time.

Agree and from what they told me they are "Working on it".. the reduction of the Restricted is pretty easy to do... have anyone one holding restricted shares that is an insider or officer of the company say they will volunteer to reduce them, notify the TA that they want restricted label removed and reissued as common and then notify the OTC... my take is they have done all of that and are currently waiting on the OTC to compete it on their end...once that is done they will have the TA update the Share Structure on the OTC to confirm its been taken care of and the Warning will be removed.

I would like to see them reduce their restricted than issue additional shares. That's what the shorts are banking on. Why accommodate? They've only kept this contained , hence the .11 insider buy in etc.
Reduce restricted and let them cover without the shares.
Just my take

It would be a big step forward if they could get the issue with the Float meeting the needed shares to then have that Warning Sign removed from the Overview page on the OTC... I know they are working on it and working with the OTC themselves is a major pain in the ass... they move at their own speed

Pleasure. Credibility here has never been an issue. Despite the time on EM they've been consistently solid in their endeavors and executions.
They don't belong on the OTC and the MMS campaign to subvert this is only going to cost them more as the forensics on shares plays into this uplist.
I suspect we will get the uplist sooner than most suspect.
Just my take.